Moreover, the accretion of adiposity and obesity are metabolic disorders associated with reduced irisin secretion, and circulating levels of irisin are found to be particularly reduced in (non-metabolically healthy) obese patients with T2D [15,16]. The gene discussed is FNDC5; the disease is Other metabolic disease.